RUNX1 and Splenomegaly: Similarly, splenomegaly was most common in SIL::TAL1 patients (100%), followed by E2A::PBX1 (75%), BCR::ABL (60%), MLL::AF4 (33.3%), TEL::AML1 (30%), negative (29.7%) and unknown (25.6%).